Dossier services
A written view on whether your product can be registered in India, by what route, on what timeline and with what risks — before you commit.
What is a pre-assessment report?
A pre-assessment report is a written feasibility assessment of a proposed registration, produced before any data is commissioned. It establishes the applicable route, whether registration is achievable, the likely obstacles, an indicative timeline, and the decisions that most affect cost — so the investment decision is made on evidence.
What it answers
Companies approach the Indian market with a commercial thesis: a molecule they manufacture, a formulation that sells elsewhere, a gap they have identified. The regulatory question is whether that thesis survives contact with the Insecticides Act, and how much it costs to find out.
A pre-assessment report answers, in writing:
- Is the molecule already registered in India, and by whom?
- Does Section 9(4) apply, or is this a 9(3) or 9(3B) programme?
- Is the substance scheduled, prohibited, restricted, or under review?
- Which registration categories does the supply chain require — TI, FI, TIM, FIM, or a combination?
- Is the intended claim supportable, or will it need narrowing?
- What are the foreseeable obstacles, and how serious is each?
- What is a realistic timeline, and what sits on the critical path?
- What decisions now would most reduce cost or risk later?
How it differs from a data gap analysis
| Pre-assessment report | Data gap analysis | |
|---|---|---|
| Question | Should we do this at all, and how? | What data do we still need? |
| Timing | Before the investment decision | After the decision, before commissioning studies |
| Focus | Feasibility, route, risk, timeline | Study-by-study inventory and sequencing |
| Audience | Commercial decision-makers | Regulatory and technical teams |
Many projects need both, in that order. A smaller number need only the gap analysis, where the commercial decision is already settled.
Where a pre-assessment changes the plan
The route is not what was assumed
A company expecting a straightforward me-too registration discovers the molecule is not registered in India in the form they intend, or their source differs materially from the reference. The project is a 9(3) programme, and the business case has to be rebuilt.
The claim has to narrow
The commercial case rests on a crop or pest the available data will not support. Better to know before the launch plan is built around it.
The supply chain needs restructuring
The intended manufacturing and shipping arrangement does not map cleanly onto the registration categories, or names entities that will cause problems at customs. Restructuring on paper is cheap; restructuring after a container is held is not.
A different product is the better entry
Occasionally the assessment shows that a different molecule in the portfolio has a materially easier path to the Indian market. Sequencing the easier registration first builds the relationship and the market position while the harder one proceeds.
For overseas companies particularly
Foreign manufacturers assessing India face compounding uncertainties: an unfamiliar regulatory regime, a partner decision, and a market they may not yet know well. A pre-assessment report gives the board a document to decide against, rather than a consultant's verbal assurance.
It also surfaces the entity question early. Whether you register through a subsidiary or an authorised Indian representative shapes who owns the registration asset, and that is much easier to decide before a partner has been chosen than afterwards.
How JDR delivers it
A written report, scoped as a discrete engagement, with our honest view rather than an encouraging one. Where we think a project is difficult, the report says so. We would rather lose a registration engagement at the assessment stage than run one that was never going to work.
Frequently Asked Questions
What is the difference between a pre-assessment report and a gap analysis?
A pre-assessment report addresses whether and how to proceed — route, feasibility, risk and timeline — before the investment decision. A gap analysis addresses what data is still required, after the decision is made and before studies are commissioned.
How long does a pre-assessment take?
Typically a short engagement of a few weeks, depending on how much information about the product and intended supply chain is available at the outset.
Will you tell me if the project is not worth doing?
Yes. That is the point of commissioning the assessment separately from the registration work. A report that only ever encourages the client is not worth paying for.
Do I need one if I already know the molecule is registered in India?
Possibly not. Where the route is clearly Section 9(4) and the supply chain is settled, a gap analysis may be the sensible starting point instead.
Is it useful for a portfolio rather than a single product?
Yes, and often more so. Assessing several products together usually reveals that one has a materially easier path, which changes the sequencing of a market entry.
Reviewed: 22 September 2026 · Reflects the Insecticides Act, 1968 and Insecticides Rules, 1971 as amended, including the Insecticides Third (Amendment) Rules, 2026 (G.S.R. 597(E) dated 8 July 2026). General guidance only — confirm current requirements before acting.
Assessing India as a market?
Get a written view on route, feasibility and timeline before the investment decision, not after.
Talk to Our Regulatory Team